Code | 3623D | ||||||||||
MA number | 27/0167/16-S | ||||||||||
Product Form: | tbl 30x1 mg (fľ.HDPE bez bezpeč.úzáveru) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
MAH, country: | Glenmark Pharmaceuticals s.r.o., Czechia | ||||||||||
Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 15 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 21.03.2016 |
SPC: |
|
PIL: |
|
Safety feature | Yes |
Data update: | 04.06.2020 |